Novartis suit in India could affect generic drug prices... Indian Case Could Impact Availability of Generic Drugs September 10, 2012 NEW DELHI Indias generic drug industry began to flourish in the 1970s when India disallowed the patenting of medicines, enabling domestic companies, which did not have to invest in research, to make copies of branded drugs at a far lower cost.
Generic medicines can be achieved by people in low rates than high reputed company drug. It will not only save money in treatment but also encourage people to take proper treatment for their illness.
India Supreme Court rejects Novartis patent... India's rejection of drug patent could reverberate Apr 1,`13 - The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. See also: Novartis India case: Campaigners hail patent rejection 1 April 2013 - Healthcare campaigners have welcomed India's rejection of a legal bid by Swiss company Novartis to patent a new version of its cancer drug, Glivec.
Perhaps a different economic model would be better, where it is the government doing the pharmaceutical research. The government may be bad at many things, but the private industry is no better than government when it comes to scientific research.
It is a Obama's government idea. Many drug prices has already changed. I am using minoxidil 20 since last one year. When I go on internet and checked the prices, it was changed and increased. And hence I need to buy it on changed prices.
